Editorial Disclosure & Methodology
Luma Health competes with Hims and stands to benefit if you choose Luma Health over Hims. This page identifies complaint patterns from publicly available patient reviews (Reddit r/semaglutide, r/Tirzepatide, BBB, Trustpilot, and similar platforms) as of June 2026. We have aimed to represent these patterns accurately and contextualize each within the GLP-1 telehealth industry broadly. Where a complaint applies to the industry generally rather than Hims specifically, we say so. Hims is a legitimate, publicly traded company (NYSE: HIMS) — these are structural friction points, not evidence of fraud or unsafe practice.
The Most Common Hims GLP-1 Complaints — With Context
Hims is one of the largest GLP-1 telehealth platforms and by volume serves more patients than most competitors. More patients means more complaints in absolute terms — a complaint rate that's proportionally normal at scale can look significant in review counts. The complaints below are patterns, not isolated incidents, and each has structural context worth understanding before deciding whether it affects your situation.
① Pricing Surprise at Maintenance Doses Hims-Specific
The most frequently reported Hims GLP-1 complaint: patients who enrolled at a starting-dose price (semaglutide ~$79–$99/mo, tirzepatide ~$199/mo) discover their monthly charge increases significantly as they reach maintenance doses (sema ~$149–$199/mo, tirz ~$299–$329/mo). The medication is the same — the dose increases, and Hims' dose-tier pricing increases with it. Patients who didn't anticipate this describe it as a surprise billing change. It isn't — Hims' pricing is dose-dependent and disclosed — but the gap between starting and maintenance pricing is among the widest in the market.
What to do about it:
Before enrolling: ask specifically "What is the price at the maintenance dose for [semaglutide/tirzepatide]?" Confirm the price at your expected stable dose before providing payment. If you're already enrolled and experiencing this: compare Hims' maintenance-dose price against alternatives. At sema maintenance, Luma Health's $197/mo flat may be lower than Hims' $149–$199/mo range. At tirz maintenance, Luma Health's $297/mo flat is comparable to or less than Hims' $299–$329/mo.
② Pharmacy Not Disclosed for Independent Verification Hims-Specific
Hims does not prominently name its specific compounding pharmacy partner(s) in consumer-facing materials. Patients who want to independently verify their medication's source — checking the pharmacy's state board license number before or after enrolling — find this information difficult to obtain without contacting support. For an injectable medication that patients self-administer weekly, pharmacy transparency matters more than for topical or oral products.
What to do about it:
If this matters to you: contact Hims support directly and ask: "What is the name of the compounding pharmacy that prepares my GLP-1 medication, and what is their state board license number?" Get the answer in writing. If pharmacy transparency is a primary concern before enrollment, consider providers that publicly name their pharmacy: Luma Health names VialsRX (TX #35264), verifiable at pharmacy.texas.gov before providing payment.
③ Slow or Difficult Customer Support Response Industry-Wide
Delayed support response is the most common complaint category across GLP-1 telehealth at scale — it's not unique to Hims. Hims serves millions of patients across multiple health conditions. Their support team handles volume across sexual health, hair loss, skincare, mental health, and weight loss simultaneously. GLP-1 clinical questions (dose adjustments, side effect management, injection technique) require provider-level responses rather than basic customer service responses, which creates additional latency. Response times of 24–72 hours for non-urgent clinical questions are common across the category.
What to do about it:
For non-urgent clinical questions: use Hims' asynchronous provider messaging and allow 48–72 hours for response. For urgent clinical concerns: contact your primary care physician, call 911, or go to urgent care rather than waiting for telehealth response. For prescription management questions (refills, dose changes): initiate at least 1–2 weeks before you need the medication.
④ Cancellation Friction and Auto-Renewal Charges Industry-Wide
Difficulty canceling subscriptions — or discovering that subscriptions auto-renewed despite attempted cancellation — is a common GLP-1 telehealth complaint across multiple platforms. Hims uses a subscription model; cancellation typically requires navigating to specific account settings within the Hims app or website. Some patients report receiving an additional month's charge after attempting to cancel, particularly if the cancellation attempt was made close to the billing date.
What to do about it:
If canceling Hims: initiate cancellation in the Hims app at least 5–7 days before your next billing date. Request written email confirmation of your cancellation with the specific effective date. If you received an unexpected charge after canceling: contact Hims support with your cancellation confirmation email; documented cancellations typically result in refunds. As a proactive measure: screenshot or photograph your cancellation confirmation screen immediately after completing the process.
⑤ Shipping Delays and Medication Arrival Timing Industry-Wide
GLP-1 medication shipping delays — particularly around billing cycles, holidays, and high-demand periods — are reported across multiple platforms including Hims. Compounded GLP-1 medications require cold-chain packaging and preparation time at the compounding pharmacy before shipping. A prescription approved on a Monday may not ship for 5–10 business days depending on pharmacy volume. Patients who time their refill order close to their last dose may experience brief gaps.
What to do about it:
Order refills proactively: initiate the refill process when you have 2–3 doses remaining, not when you're at your last dose. Track your shipment actively: Hims typically provides tracking information — use it to identify any delays early. If you experience a significant delay: contact Hims support, document the date you contacted them, and request expedited shipping or compensation for documented delays.
⑥ Limited GLP-1 Clinical Depth (Generalist Platform) Hims-Specific
Hims is a generalist multi-condition telehealth platform — weight loss is one of multiple health categories alongside sexual health, hair, skincare, and mental health. Some patients report that their GLP-1 prescribing experience feels less clinically specialized than platforms focused exclusively on metabolic health. Provider interactions are primarily asynchronous (no video consultations for GLP-1); clinical guidance on side effect management, titration nuances, and concurrent medications may receive generic responses rather than specialized GLP-1 clinical expertise.
What to do about it:
For complex clinical questions about GLP-1 pharmacology, drug interactions, or management of persistent side effects: supplement Hims with your primary care physician or a registered dietitian who specializes in GLP-1 patients. If specialized GLP-1 clinical support is your primary need, platforms with GLP-1-specific clinical focus may provide more nuanced responses.
What Hims Does Well — The Genuine Strengths
✓ Hims' Genuine Clinical and Platform Strengths
- ✓ NYSE-listed public company (HIMS) — institutional stability and regulatory accountability that smaller platforms don't match
- ✓ Lowest starting-dose semaglutide price in market (~$79–$99/mo) — meaningful for patients in the first 2–3 months of titration
- ✓ Multi-condition platform — convenient for patients who also use Hims for hair loss, sexual health, or other conditions
- ✓ Polished app experience — weight tracking, provider messaging, and subscription management in one interface
- ✓ Fast onboarding — provider review typically within 24–48 hours; first medication often arrives within 5–10 days
- ✓ Both sema and tirz available — patients can switch medications within the platform
If You're Currently Having a Problem With Hims
Immediate Steps by Problem Type
1
Unexpected billing charge: Screenshot the charge, check your Hims account for any plan change notifications, contact Hims support via the app with the specific charge date and amount. Ask for a written response and refund timeline if the charge was in error.
2
Shipping delay: Check your tracking information in the Hims app. If no tracking has been issued 10 business days after your prescription was approved, contact support and explicitly request a status update and a new ETA. Document the date you contacted them.
3
Clinical question not getting answered: For urgent clinical concerns, contact your primary care physician rather than waiting for async telehealth response. For non-urgent questions, send a detailed written message via the Hims app and allow 48–72 hours. If still unresolved after 72 hours, escalate via support chat.
4
Cancellation difficulty: Navigate to account settings → subscription management in the Hims app and follow the cancellation flow. If the cancellation flow isn't working, contact Hims support and explicitly state "I want to cancel my subscription effective immediately." Request written email confirmation with effective date within 24 hours.
5
Considering switching providers: Start your new provider's intake before canceling Hims to avoid any medication gap. Wait for your new medication's tracking confirmation before canceling. Switching from Hims to Luma Health: start at start.mylumahealth.com with your current dose information, then cancel Hims after VialsRX shipping is confirmed.
Frequently Asked Questions
Is Hims a legitimate and safe platform for GLP-1?
Yes. Hims (NYSE: HIMS) is a publicly traded telehealth company with licensed clinical infrastructure and FDA-registered compounding pharmacy partners. The complaints documented on this page are structural friction points — pricing complexity, support response times, limited pharmacy disclosure — rather than safety or legitimacy concerns. Compounded semaglutide and tirzepatide prescribed through Hims use the same active pharmaceutical molecules as Wegovy and Zepbound, prepared by licensed 503A pharmacies. The clinical safety of the medication is not what's in question; the service model's limitations are what patient complaints typically address.
Why does Hims' GLP-1 price increase after a few months?
Hims uses dose-tier pricing — monthly cost increases as your GLP-1 dose increases during titration. Semaglutide starts at approximately $79 to $99/month at 0.25 mg/week and increases to $149 to $199/month at maintenance doses (1.7–2.4 mg/week). Tirzepatide starts at approximately $199/month and increases to $299 to $329/month at maintenance doses. This is a structural feature of Hims' pricing model, not a billing error. The increase is real and should be verified before enrollment. Ask: "What is the monthly price at maintenance dose?" to understand your full-course cost before committing.
How do I cancel Hims GLP-1 without problems?
Cancel at least 5 to 7 days before your next billing date. Log into the Hims app, navigate to account settings, and find subscription management. Follow the cancellation flow completely — don't exit before receiving confirmation. Request email confirmation of your cancellation with the specific effective date. Screenshot the confirmation screen. If canceling via support chat rather than self-serve: get written confirmation of cancellation in the chat, then request a follow-up email. If you receive an unexpected charge after canceling with documented confirmation, contact support with your evidence — these disputes are typically resolved with a refund.
What is Hims' compounding pharmacy for GLP-1?
Hims does not prominently disclose the specific name of its GLP-1 compounding pharmacy in public-facing materials. To obtain this information, contact Hims support directly and ask for the compounding pharmacy's name and state board license number. This is a reasonable request for any patient using an injectable compounded medication. For comparison, Luma Health publicly names VialsRX (Texas State Board of Pharmacy license #35264) — independently verifiable at pharmacy.texas.gov before payment.
Should I switch from Hims to Luma Health?
It depends on which complaint applies to you. For pricing complaints at maintenance doses: Hims' sema maintenance (~$149–$199/mo) is comparable to Luma Health's $197/mo flat; Hims' tirz maintenance (~$299–$329/mo) is comparable to or higher than Luma Health's $297/mo flat. The switching advantage is primarily predictability — Luma Health's flat rate never increases with dose. For pharmacy transparency concerns: Luma Health names VialsRX (TX #35264) publicly. For cancellation flexibility: Luma Health has no contracts and simpler cancellation. If you're satisfied with Hims at your current dose and price, there's no compelling reason to switch on pricing grounds alone unless you're at high maintenance doses where Luma Health becomes cost-competitive.
Are Hims' GLP-1 complaints unusually bad compared to other platforms?
Hims' complaint volume in absolute terms is high because their patient volume is high. Proportionally, many of the complaints — shipping delays, support response times, cancellation friction — appear across the GLP-1 telehealth category at similar rates. The dose-tier pricing surprise is more Hims-specific because their price gap between starting and maintenance doses is wider than most platforms. The pharmacy non-disclosure is also more notable at Hims than at platforms like Ro (which names their own pharmacy) or Luma Health (which names VialsRX). Hims is not uniquely problematic — it's a large-scale generalist platform with the service model trade-offs that come with generalist scale.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed
- FDA. Human Drug Compounding — Section 503A. FDA.gov
- FDA. BeSafeRx — Online Pharmacy Verification. FDA.gov
- NABP. Compounding Pharmacy Accreditation. nabp.pharmacy
- Hims & Hers Health. Weight Loss Program. hims.com
- Better Business Bureau. Hims & Hers Health Business Profile. bbb.org
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov
Medical Disclaimer: This article documents structural complaint patterns reported in patient communities. It does not constitute a safety warning — Hims is a legitimate telehealth platform. Luma Health competes with Hims — readers should consider our competitive bias. Complaint patterns were identified from publicly available patient reviews as of June 2026. Clinical services at Luma Health are provided by Wasef Health, PC. Compounded medications prepared by VialsRX, TX Board #35264.